Women with particularly aggressive forms of breast cancer could be identified by a test that predicts whether the disease is likely to spread to the brain. An analysis of almost 4,000 patients with breast cancer found that testing for high activity in a particular gene could pick out women who were at greater risk of developing secondary brain tumors compared to women who tested negative.